menu search

Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities to Address Expanding Psychedelic Drug Development Market

Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities to Address Expanding Psychedelic Drug Development Market
Company Secures Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency, Expands on 25 Years of Manufacturing of Schedule 2 Products No Additional Investment Required to Support Clinical Trials for Psychedelic-Based Therapeutics SAN DIEGO and GAINESVILLE, Ga., July 26, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal CDMO”; Nasdaq: SCTL), a contract development and […] The post Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities t... Read More
Posted: Jul 26 2023, 11:00
Author Name: forextv
Views: 102016

Search within

Pages Search Results: